COMP <GO>
BMGL vs ATPC // ENTERPRISE SCALE & MARKET CAP
Basel Medical Group Ltd (NASDAQ) VS. Agape ATP Corporation (NASDAQ) • 15-METRIC TALLY: BMGL 2
— ATPC 0
▲ ENTERPRISE SCALE & MARKET CAP LEADER: BMGL
LAST: $5.04 (+6.11%) • MKT CAP: $36.0M
market-cap
$36.0M
LAST: $1.45 (-10.22%) • MKT CAP: $1.6M
market-cap
$1.6M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BMGL VS. ATPC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BMGL | ATPC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 55.00% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -11.50% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 15.20% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.49 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 4/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.5 | 33.2 | +26.33 | BMGL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $36.0M | $1.6M | $34.4M | BMGL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BMGL REV | ATPC REV | BMGL GROSS % | ATPC GROSS % | BMGL FCF | ATPC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $1.5M | — | 55.0% | — | -$2.4M |
| FY 2024 | — | $1.3M | — | 57.4% | — | -$2.7M |
| FY 2023 | — | $1.4M | — | — | — | -$2.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BMGL // BETA —
ATPC // BETA —